BULLISHWHALES
BullishWhales · Analysts · Analyst Profile

Naz Rahman

Maxim Group · Equity Research Analyst

Analyst rating accuracy & track record

Naz Rahman does not yet have enough resolved 12-month calls to carry a published score. Check back as their ratings mature.

Ratings & price targets

StockRatingPrice targetRated12-mo vs sectorPT hit
NVCTNuvectis Pharma Inc
Buy$17.00Apr 2025−20.9%Miss
SLXNBiomotion Sciences Ordinary Shares
Buy$5.00Mar 2025−93.7%Miss
VKTXViking Therapeutics Inc
Buy$70.00Feb 2025−11.6%Miss
CINGCingulate Inc
BuyNov 2024−32.6%
PALIPalisade Bio Inc
Buy$8.00Nov 2024−36.2%Miss
SLXNBiomotion Sciences Ordinary Shares
Buy$1.00Nov 2024−16.3%Hit
ASRTAssertio Therapeutics Inc
Buy$3.00Jul 2024−42.0%Miss
PRFXPainreform Ltd
Buy$2.00Jun 2024−81.5%Hit
PALIPalisade Bio Inc
Buy$22.50May 2024−88.1%Miss
PALIPalisade Bio Inc
Buy$22.50Apr 2024−89.4%Miss
PTPIPetros Pharmaceuticals Inc
Buy$4.00Dec 2023−101.5%Miss
PALIPalisade Bio Inc
Buy$1.50Nov 2023−85.2%Miss
AYTUAytu BioScience Inc
Buy$5.00Aug 2023+23.7%Miss
PALIPalisade Bio Inc
Buy$50.00Mar 2023−103.9%Miss
PCSAProcessa Pharmaceuticals Inc
Buy$5.00Jan 2023−84.4%Miss
CINGCingulate Inc
Buy$3.00Nov 2022−57.7%Miss
PCSAProcessa Pharmaceuticals Inc
Buy$9.00Apr 2022−79.8%Miss
NXGLNexgel Inc
Buy$6.00Feb 2022−25.6%Miss
NRSNNeurosense Therapeutics Ltd
Buy$7.00Jan 2022−51.0%Hit
Go to

Browse the full analyst leaderboardHow analyst accuracy is scored

Every score, Win %, PT Hit % and rank is an estimate Bullish Whales calculates from its own data and may not be 100% accurate or complete. Returns are measured in excess of each rated stock's own sector over the 12 months after each call. Past performance does not guarantee future results, and nothing here is a recommendation to buy or sell any security.

v1.0.30